NRx Pharmaceuticals Inc Asset Resilience Ratio
NRx Pharmaceuticals Inc asset resilience ratio. NRx Pharmaceuticals Inc (NRXPW) has an Asset Resilience Ratio of 99.01% as of March 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See NRx Pharmaceuticals Inc (NRXPW) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of NRx Pharmaceuticals Inc (2017–2019)
Asset resilience ratio of NRx Pharmaceuticals Inc from 2017 to 2019. This chart shows how NRx Pharmaceuticals Inc's Asset Resilience Ratio has changed over time. Read NRx Pharmaceuticals Inc (NRXPW) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down NRx Pharmaceuticals Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see NRXPW current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $5.97 Million | 99.01% |
| Total Liquid Assets | $5.97 Million | 99.01% |
Asset Resilience Insights
- Very High Liquidity: NRx Pharmaceuticals Inc maintains exceptional liquid asset reserves at 99.01% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
NRx Pharmaceuticals Inc Industry Peers by Asset Resilience Ratio
Compare NRx Pharmaceuticals Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
| No industry peers found with asset resilience data. | ||
NRx Pharmaceuticals Inc Asset Resilience Ratio by Year (2017–2019)
NRx Pharmaceuticals Inc asset resilience ratio by year from 2017 to 2019. The table below shows the annual Asset Resilience Ratio data for NRx Pharmaceuticals Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2019-12-31 | 99.78% | $32.01 Million | $32.07 Million | -0.17pp |
| 2018-12-31 | 99.96% | $70.77 Million | $70.80 Million | +0.73pp |
| 2017-12-31 | 99.23% | $69.03 Million | $69.57 Million | -- |
About NRx Pharmaceuticals Inc
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone… Read more